胸痛风险评分在急性胸痛患者危险分层中应用的研究进展  

Research Progress on the Application of Chest Pain Risk Score in Risk Stratification of Patients with Acute Chest Pain

作　　者：于菁怡 邢家璇 徐雅妮 

机构地区：[1]山东大学齐鲁医院(第一临床学院),山东 济南

出　　处：《临床医学进展》2024年第5期1828-1835,共8页Advances in Clinical Medicine

摘　　要：急性胸痛患者在急诊门诊就诊的患者中占比较大,早期明确诊断并进行危险分层有利于改善患者预后。胸痛病因复杂,分为心源性胸痛和非心源性胸痛,其中较常见的为急性冠脉综合征。目前指南推荐的胸痛风险评分包括HEART评分、EDACS评分、ADAPT评分、hs-cTn评分、TIMI评分和GRACE评分,这些评分各有优劣,但均缺少我国人群数据支持,且大多数建立在动态监测肌钙蛋白基础上,未来有待进一步验证评分效能或创建基于我国人群的危险分层模型。Acute chest pain accounts for a large proportion of emergency outpatient patients, and early diagnosis and risk stratification are beneficial to improve patient prognosis. The etiology of chest pain is complex, including cardiogenic chest pain and non-cardiogenic chest pain, of which acute coronary syndrome is the most common. The chest pain risk scores recommended in the current guidelines include HEART score, EDACS score, ADAPT score, hs-cTn score, TIMI score, and GRACE score. Each of these scores has its advantages and disadvantages, but all of them lack the support of Chinese population data, and most of them are based on dynamic monitoring of troponin. In the future, it is necessary to further validate the scoring efficacy or create a risk stratification model based on Chinese population.

关 键 词：急性冠脉综合症 胸痛风险评分 危险分层 预后 

分 类 号：R54[医药卫生—心血管疾病]